The CD16+ (FcγRIII+) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting

Journal of Experimental Medicine

Volumn 196, Issue 4, 2002, Pages 517-527

  Randolph, Gwendalyn J ^a   Sanchez Schmitz, Guzman ^a   Liebman, Ronald M ^a   Schäkel, Knut ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Antigen presentation; Cell differentiation; Cell survival; IgG receptors; Transforming growth factors

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; FC RECEPTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; TRANSFORMING GROWTH FACTOR BETA1; ZYMOSAN; BIOLOGICAL MARKER; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE HOMING; MIXED LYMPHOCYTE REACTION; MODEL; MONOCYTE; PRIORITY JOURNAL; BIOLOGICAL MODEL; CELL MOTION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANTIGEN-PRESENTING CELLS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELLS; HLA-DR ANTIGENS; HUMANS; MODELS, IMMUNOLOGICAL; MONOCYTES; RECEPTORS, IGG; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; ZYMOSAN;

EID: 0037135659     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011608     Document Type: Article

References (45)

1. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
2. Isolation and characterization of human peripheral blood dendritic cells
3. The nature of the principal type 1 interferon-producing cells in human blood
4. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
5. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
6. + dendritic cells
7. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF
8. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
9. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: Role of intercellular adhesion molecule 1 and the CD11/ CD18 integrins
10. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
11. Dendritic cell migration to lymph nodes: Cytokines, chemokines, and lipid mediators
12. Identification and characterization of a novel monocyte subpopulation in human peripheral blood
13. Granulocyte-macrophage colony-stimulating factor antagonizes the transforming growth factor-beta-induced expression of Fc gamma RIII (CD16) on human monocytes
14. A novel dendritic cell population in human blood: One-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes
15. The M-DC8-positive leukocytes are a subpopulation of the CD14+ CD16+ monocytes
16. Identification of a novel dendritic cell-like subset of CD64(+) / CD16(+) blood monocytes
17. Monocyte-selective transendothelial migration: Dissection of the binding and transmigration phases by an in vitro assay
18. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro
19. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation
20. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
21. The dendritic cell system and its role in immunogenicity
22. Interleukin-10 drives human monocytes to CD16 positive macrophages
23. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: Differential response to in vivo administration of rhM-CSF or rhGM-CSF
24. CD16+ monocytes in patients with cancer: Spontaneous elevation and pharmacologic reduction by recombinant human macrophage colony-stimulating factor
25. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells
26. Tissue distribution of human IgG Fc receptors CD16, CD32 and CD64: An immunohistochemical study
27. CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes
28. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics
29. The origin and kinetics of mononuclear phagocytes
30. CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy
31. Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy
32. CD14lowCD16high: A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection
33. Unique monocyte subset in patients with AIDS dementia
34. HIV infection and dementia
35. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity
36. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells
37. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells
38. CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells
39. Biasing immune responses by directing antigen to macrophage Fcgamma receptors
40. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice
41. Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis
42. Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation
43. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors
44. Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcgammaRIII) whose engagement blocks the cell death programme and facilitates differentiation
45. Fc gamma receptors and cross-presentation in dendritic cells